Taipei, Taiwan

Bi-Fong Lin

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Bi-Fong Lin: Innovator in Immunostimulatory Compounds

Introduction

Bi-Fong Lin is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of immunology through his innovative research and development of compounds that exhibit immunostimulatory and anti-inflammatory effects. With a total of 4 patents, Lin's work has the potential to impact the treatment of various inflammatory disorders.

Latest Patents

Among his latest patents, Lin has disclosed isolated compounds or pharmaceutically acceptable salts derived from the fruiting body of a solid culture. These compounds are designed to stimulate immune responses and treat inflammatory disorders. Additionally, he has developed methods for utilizing these compounds in pharmaceutical compositions, showcasing his commitment to advancing medical science.

Career Highlights

Lin has worked with Well Shine Biotechnology Development Co., Ltd. and National Taiwan University, where he has been able to apply his research in practical settings. His work has not only contributed to academic knowledge but has also paved the way for potential therapeutic applications in the pharmaceutical industry.

Collaborations

Lin has collaborated with esteemed colleagues, including Yueh-Hsiung Kuo and Ching-jang Huang, who have supported his research endeavors. These collaborations have enriched his work and expanded the impact of his innovations.

Conclusion

Bi-Fong Lin's contributions to the field of immunology through his patents and collaborations highlight his role as a significant inventor. His work continues to inspire advancements in the treatment of inflammatory disorders, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…